Abstract:Deacetylcephalosporin C synthase (DACS), a 2-oxoglutarate-dependent oxygenase synthesized by Streptomyces clavuligerus, transforms an inert methyl group of deacetoxycephalosporin C (DAOC) into an active hydroxyl group of deacetylcephalosporin C (DAC) during the biosynthesis of cephalosporin. It is a step which is chemically difficult to accomplish, but its development by use of an enzymatic method with DACS can facilitate a cost-effective technology for the manufacture of semisynthetic cephalosporin intermediates such as 7-amino-cephalosporanic acid (7ACA) and hydroxymethyl-7-amino-cephalosporanic acid (HACA) from cephalosporin G. As the native enzyme showed negligible activity toward cephalosporin G, an unnatural and less expensive substrate analogue, directed-evolution strategies such as random, semirational, rational, and computational methods were used for systematic engineering of DACS for improved activity. In comparison to the native enzyme, several variants with improved catalytic efficiency were found. The enzyme was stable for several days and is expressed in soluble form at high levels with significantly higher kcat/Km values. The efficacy and industrial scalability of one of the selected variants, CefFGOS, were demonstrated in a process showing complete bioconversion of 18 g/liter of cephalosporin G into deacetylcephalosporin G (DAG) in about 80 min and showed reproducible results at higher substrate concentrations as well. DAG could be converted completely into HACA in about 30 min by a subsequent reaction, thus facilitating scalability toward commercialization. The experimental findings with several mutants were also used to rationalize the functional conformation deduced from homology modeling, and this led to the disclosure of critical regions involved in the catalysis of DACS. Importance: 7ACA and HACA serve as core intermediates for the manufacture of several semisynthetic cephalosporins. As they are expensive, a cost-effective enzyme technology for the manufacture of these intermediates is required. Deacetylcephalosporin C synthase (DACS) was identified as a candidate enzyme for the development of technology from cephalosporin G in this study. Directed-evolution strategies were employed to enhance the catalytic efficiency of deacetylcephalosporin C synthase. One of the selected mutants of deacetylcephalosporin C synthase could convert high concentrations of cephalosporin G into DAG, which subsequently could be converted into HACA completely. As cephalosporin G is inexpensive and readily available, the technology would lead to a substantial reduction in the cost for these intermediates upon commercialization.

Progress in enzymatic conversion of cephalosporin C to 7-aminocephalosporanic acid

Research Progress in One-Step Enzymatic Conversion of Cephalosporin C to 7-Aminocephalosporanic Acid

Enzymatic transformation of cephalosporin C to 7-amino-cephalosporanic acid. Part II: Single-step procedure using a coimmobilized enzyme system

Research progress on cephalosporin acylase for 7-ACA preparation

Characterization and engineering of cephalosporin C acylases to produce 7-Aminocephalosporanic acid

Construction and Application of Fusion Proteins of D-Amino Acid Oxidase and Glutaryl-7-Aminocephalosporanic Acid Acylase for Direct Bioconversion of Cephalosporin C to 7-Aminocephalosporanic Acid

Enzymatic transformation of cephalosporin C to 7-amino-cephalosporanic acid. Part I: Cultivation of Pseudomonas syringae and partial purification and immobilization of 7-β-(4-carboxybutanamido) cephalosporanic acid acylase

Two Step Enzymatic Production of 7-Aminocephalosporanic Acid by Coupling Free Cells Catalysis with Hollow Fiber Membrane Separation

A Straightforward Approach to Synthesize 7-Aminocephalosporanic Acid In Vivo in the Cephalosporin C Producer Acremonium chrysogenum

Characteristic of Immobilized Cephalosporin C Acylase and Its Application in One-Step Enzymatic Conversion of Cephalosporin C to 7-Aminocephalosporanic Acid

Strategic manipulation of an industrial biocatalyst--evolution of a cephalosporin C acylase

Construction of Recombinant Escherichia Coli D11/pMSTO and Its Use in Enzymatic Preparation of 7-Aminocephalosporanic Acid in One Pot

Modified Deacetylcephalosporin C Synthase for the Biotransformation of Semisynthetic Cephalosporins

Directed Evolution of Cephalosporin C Acylase Activity by Error-prone PCR

Enhancement of Enzymatic Adipyl-7-ADCA Hydrolysis

Possibilities to acylate 7-aminocephalosporanic acid to obtain some cephalosporins

Biochemical characterization of an acetylesterase from Bacillus subtilis and its application for 7-aminocephalosporanic acid deacetylation

Cloning and co-expression of d-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase genes in Escherichia coli

An Improved Process For The Preparation Of Diphenylmethyl 7 Beta-Phenylacetamido-3-Hydroxymethyl-3-Cephem-4-Carboxylate

Artificial Synthesis and Expression of the CPC Acylase Gene in Recombinant E.coli

Study on Thermodynamics and Kinetics of Cephalexin Enzymatic Hydrolysis and Its Process Development to Prepare 7-ADCA